The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
Mark For: TULVEGIO RIVOCERANIB™ trademark registration is intended to cover the category of
>Color is not claimed as a feature of the mark. The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88620374 |
Mark Literal Elements | TULVEGIO RIVOCERANIB |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2023-08-21 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Grant R. Clayton |
Attorney Docket Number | T13458 |
Law Office Assigned | M80 |
Employee Name | GARDNER, DAWNA BERYL |
2019-09-17 | Application Filed |
2019-11-16 | Location: LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED |
2019-11-16 | Status: Live/Pending |
2019-11-16 | Transaction Date |
2021-06-22 | Published |
2023-08-21 | Location: INTENT TO USE SECTION |
2024-02-13 | Status: A fifth request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UTAH UNITED STATES 84121 |
Legal Entity Type | Corporation |
Legal Entity State | UTAH |
Party: | ![]() |
Address | 2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UTAH UNITED STATES 84121 |
Legal Entity Type | Corporation |
Legal Entity State | UTAH |
02.11.14 | Finger pointing (gesture); Fingers walking (gesture); Gestures (OK, thumbs up, thumbs down, fingers walking, handshake, finger pointing); Hands and fingers forming the following: handshake, finger pointing, fingers walking, OK sign, and thumbs up or thumbs down; Handshake (gesture); OK gesture; Thumbs up or thumbs down (gesture) |
021107 | Arms; Fingers; Hands; Human hands, fingers, arms |
021114 | Finger pointing (gesture); Fingers walking (gesture); Gestures (OK, thumbs up, thumbs down, fingers walking, handshake, finger pointing); Hands and fingers forming the following: handshake, finger pointing, fingers walking, OK sign, and thumbs up or thumbs down; Handshake (gesture); OK gesture; Thumbs up or thumbs down (gesture) |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
IC 035. US 100 101 102. G & S: Marketing in the field of cancer treatments containing rivoceranib
IC 042. US 100 101. G & S: Development of therapeutics for the treatment of cancer containing rivoceranib
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date |
---|---|
![]() | 2020-04-16 |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-02-14 | |
SOU TEAS EXTENSION RECEIVED | 2024-02-13 | |
SOU EXTENSION 5 GRANTED | 2024-02-13 | |
SOU EXTENSION 5 FILED | 2024-02-13 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-08-22 | |
SOU EXTENSION 4 GRANTED | 2023-08-21 | |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-08-21 | |
SOU TEAS EXTENSION RECEIVED | 2023-08-15 | |
SOU EXTENSION 4 FILED | 2023-08-15 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-17 | |
SOU TEAS EXTENSION RECEIVED | 2023-02-15 | |
SOU EXTENSION 3 GRANTED | 2023-02-15 | |
SOU EXTENSION 3 FILED | 2023-02-15 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-03 | |
TEAS EXTENSION RECEIVED | 2022-08-01 | |
SOU TEAS EXTENSION RECEIVED | 2022-08-01 | |
SOU EXTENSION 2 GRANTED | 2022-08-01 | |
SOU EXTENSION 2 FILED | 2022-08-01 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-06-08 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-06-08 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-06-08 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-06-08 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-06-08 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-19 | |
TEAS EXTENSION RECEIVED | 2022-02-17 | |
SOU TEAS EXTENSION RECEIVED | 2022-02-17 | |
SOU EXTENSION 1 GRANTED | 2022-02-17 | |
SOU EXTENSION 1 FILED | 2022-02-17 | |
EXTENSION 1 GRANTED | 2022-02-17 | 98765 |
EXTENSION 1 FILED | 2022-02-17 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-08-17 | |
PUBLISHED FOR OPPOSITION | 2021-06-22 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-06-22 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-06-02 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-05-19 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-05-19 | |
EXAMINERS AMENDMENT E-MAILED | 2021-05-19 | |
EXAMINERS AMENDMENT -WRITTEN | 2021-05-19 | |
EXAMINER'S AMENDMENT ENTERED | 2021-05-19 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-05-19 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-05-19 | |
ASSIGNED TO LIE | 2021-05-17 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-02-09 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-01-08 | |
NON-FINAL ACTION WRITTEN | 2021-01-08 | |
NON-FINAL ACTION E-MAILED | 2021-01-08 | |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2021-01-04 | |
WITHDRAWN FROM PUB - OG REVIEW QUERY | 2020-12-29 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-12-15 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-12-14 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-12-14 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-12-14 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-12 | |
NON-FINAL ACTION WRITTEN | 2020-06-12 | |
NON-FINAL ACTION E-MAILED | 2020-06-12 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-18 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-16 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-16 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-16 | |
NON-FINAL ACTION WRITTEN | 2019-11-16 | |
NON-FINAL ACTION E-MAILED | 2019-11-16 | |
ASSIGNED TO EXAMINER | 2019-11-12 | |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-09-25 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-09-24 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2019-09-24 | |
NEW APPLICATION ENTERED IN TRAM | 2019-09-20 | |
NEW APPLICATION ENTERED | 2019-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.